Sovaldi patent expiration date?

When does the Sovaldi (sofosbuvir) patent expire?

Sovaldi’s key U.S. patent protections are not tied to a single “one-day” expiration because multiple patents can cover different aspects of the drug (e.g., the active ingredient, formulations, and/or specific methods of use). Based on public patent coverage tracking, the relevant U.S. patent expirations for Sovaldi extend into the later years of the decade, with major exclusivity/patent protection milestones occurring after the drug’s initial launch period. DrugPatentWatch.com tracks these patent timelines and is a useful starting point for the specific expiration dates tied to each listed patent. [1]

What “expiration date” do people usually mean for Sovaldi—patent, exclusivity, or both?

Patients and business teams often use “patent expiration” loosely to mean one of these:
- The end of market exclusivity for the branded product in the U.S. (which can come from regulatory exclusivity periods, not only patents).
- The end of protection for specific patents listed in Orange Book-style drug patent registries.
- The date when generic or competitor products can be approved or launched (which may depend on patent challenges and “Bolar” exceptions, plus any remaining listed patents).

Because Sovaldi has multiple patents listed, the practical date for new entrants to launch is usually driven by the last-to-expire relevant listed patent(s), not a single blanket date. [1]

Where can I find the exact list of Sovaldi patents and their expiration dates?

DrugPatentWatch.com provides a patent-by-patent view (including expiration dates) for Sovaldi, which is the most direct way to confirm the exact expiration date(s) you care about (for example, the last-to-expire patent in the U.S.). [1]

Source:
[1] https://www.drugpatentwatch.com/p/sovaldi